BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 31, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 30, 2000
View Archived Issues
Process of neurodegeneration linked to calpain activation
Read More
Receptor linked to sensitivity to inflammatory pain
Read More
FDA approves first drug to treat growth failure in children with Prader-Willi syndrome
Read More
NitroMed patents series of nitrosated or nitrosylated H2 antagonists
Read More
Cel-Sci receives permission to start phase II cancer trial in Canada
Read More
FDA approves Bayer's next-generation hemophilia A treatment
Read More
Tripos and Lipha to collaborate on drug discovery for metabolic and associated diseases
Read More
DuPont selects DPC-423 for clinical evaluation as an orally active anticoagulant
Read More
AWD-12-343 compares favorably with known PDE4 inhibitors in model of lung inflammation
Read More
Two new EP1 receptor antagonists under development at Ono for pain and cancer
Read More
Experimental study suggests potential of CP-0597 in the management of spinal cord injury
Read More
New market launch for Azopt
Read More
E.U. approves Remicade for rheumatoid arthritis
Read More
May launch announced for UCB H2 receptor antagonist
Read More
Late-stage anxiolytic candidate dropped from Welfide development pipeline
Read More
Axokine phase I results reported at ENDO 2000 meeting
Read More
Peptide Therapeutics reports positive phase III results for yellow fever vaccine
Read More
Enrollment in phase III trial of sepsis treatment stopped by Lilly
Read More
IGFAM: new members of the human immunoglobulin superfamily discovered by Incyte
Read More
Identification and potential uses of new RING finger protein revealed
Read More
New iNOS inhibitors claimed by AstraZeneca for use in inflammation and pain
Read More
U.K. scientists present new agents with vasodilating and antiplatelet properties
Read More
Cathepsin K inhibitors designed at SB for bone and cartilage disorders
Read More
Novel diagnostic test for tuberculosis with advantages over current tests
Read More
Antimicrobial and immunostimulating heterocycles synthesized at Natural Drug Sciences
Read More
Novel Vernalis compounds combine antioxidant and iron-chelating activity
Read More
FDA approves Targretin gel for treatment of cutaneous T-cell lymphoma
Read More
